Radiolabeling an Electronic Cigarette Aerosol Using Technetium Carbon Ultrafine Particles.

BACKGROUND Electronic cigarettes (ECIGs) are widely used, but their health effects are not well known. ECIG exposure is difficult to quantify, and a direct measurement of deposition would be beneficial to in vivo and in vitro toxicity studies. The aim of this study was to demonstrate effective radiolabeling of an ECIG. METHODS A technetium-99m-labeled carbon ultrafine (TCU) aerosol was generated and introduced to a fourth-generation ECIG before nucleation and aerosol formation. The aerosolized e-liquid was a commercially available strawberry flavor containing 1.2% nicotine in a 55% propylene glycol and 45% vegetable glycerine base. An ECIG power setting of 100 W was selected. Mass and radioactivity were measured on each stage within a Sierra Cascade Impactor at 14 L/min to verify the labeling technique using the calculated aerodynamic diameters. A strong positive correlation (R2 > 0.95) between the percent activity and percent mass deposition on each stage provides a reliable validation of colocation. RESULTS Unlabeled ECIG aerosol from the chosen e-liquid produced a mass median aerodynamic diameter (MMAD) of 0.85 μm. An ECIG labeled with TCU produced an aerosol with an activity median aerodynamic diameter of 0.84 μm and an MMAD of 0.84 μm. The relative mass versus radioactivity on each plate was highly correlated (average R2 = 0.973, p < 0.001). CONCLUSION A TCU radiolabel was generated and shown to associate with the mass of an aerosol produced by a typical commercially available ECIG. Thus, the radioactivity of the deposited aerosol may be used to determine ECIG aerosol deposition for the future in vivo and in vitro dosimetry studies of the third- and fourth-generation ECIGs.

[1]  I. Jaspers,et al.  Electronic Cigarettes: Their Constituents and Potential Links to Asthma , 2017, Current Allergy and Asthma Reports.

[2]  Haibo Zhou,et al.  Temporal structure/function variation in cultured differentiated human nasal epithelium associated with acute single exposure to tobacco smoke or E-cigarette vapor , 2017, Inhalation toxicology.

[3]  Christopher S. Tucker,et al.  Prototype e-cigarette and the capillary aerosol generator (CAG) comparison and qualification for use in subchronic inhalation exposure testing , 2016 .

[4]  Neal L. Benowitz,et al.  Electronic Cigarettes : Not All Good News ? E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke , 2016 .

[5]  A. Rostami,et al.  Evaporation and condensation of multicomponent electronic cigarette droplets and conventional cigarette smoke particles in an idealized G3–G6 triple bifurcating unit , 2015 .

[6]  Da-Ren Chen,et al.  In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. , 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[7]  H. Chan,et al.  Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products. , 2012, Journal of aerosol medicine and pulmonary drug delivery.

[8]  J. Fleming,et al.  Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled products. , 2012, Journal of aerosol medicine and pulmonary drug delivery.

[9]  P Worth Longest,et al.  In Silico Models of Aerosol Delivery to the Respiratory Tract — Development and Applications ☆ Advanced Drug Delivery Reviews , 2022 .

[10]  Hak-Kim Chan,et al.  In vitro/in vivo comparisons in pulmonary drug delivery. , 2008, Journal of aerosol medicine and pulmonary drug delivery.

[11]  Günter Oberdörster,et al.  Ultrafine particle deposition in subjects with asthma. , 2004, Environmental health perspectives.

[12]  W. Kreyling,et al.  Translocation of Inhaled Ultrafine Particles to the Brain , 2004, Inhalation toxicology.

[13]  Günter Oberdörster,et al.  Ultrafine Particle Deposition in Humans During Rest and Exercise , 2003, Inhalation toxicology.

[14]  James S. Brown,et al.  Ultrafine particle deposition and clearance in the healthy and obstructed lung. , 2002, American journal of respiratory and critical care medicine.

[15]  Robert Gelein,et al.  EXTRAPULMONARY TRANSLOCATION OF ULTRAFINE CARBON PARTICLES FOLLOWING WHOLE-BODY INHALATION EXPOSURE OF RATS , 2002, Journal of toxicology and environmental health. Part A.

[16]  Magnus Svartengren,et al.  Basic Principles of Particle Behavior in the Human Respiratory Tract , 2001 .

[17]  W. Bennett,et al.  Generation of Radiolabeled "Soot-Like" Ultrafine Aerosols Suitable for Use in Human Inhalation Studies , 2000 .

[18]  I. Gonda Scintigraphic techniques for measuring in vivo deposition. , 1996, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[19]  F. Löffler,et al.  Investigations of a new aerosol generator for the production of carbon aggregate particles , 1993 .

[20]  M. L. Laucks,et al.  Aerosol Technology Properties, Behavior, and Measurement of Airborne Particles , 2000 .

[21]  M. Sundahl,et al.  Aerodynamic particle size distribution and dynamic properties in aerosols from electronic cigarettes , 2017 .

[22]  L. Stabile,et al.  Influential parameters on particle concentration and size distribution in the mainstream of e-cigarettes. , 2014, Environmental pollution.

[23]  M. Dolovich,et al.  Measuring total and regional lung deposition using inhaled radiotracers. , 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[24]  J. Heyder,et al.  Deposition of particles in the human respiratory tract in the size range 0.005–15 μm , 1986 .